1. Home >
  2. Getinge Acquires Healthmark

M&A Deal Summary

Getinge Acquires Healthmark

On October 11, 2023, Getinge acquired medical products company Healthmark for 320M USD

Acquisition Highlights
  • This is Getinge’s 6th transaction in the Medical Products sector.
  • This is Getinge’s 2nd largest (disclosed) transaction.
  • This is Getinge’s 6th transaction in the United States.
  • This is Getinge’s 1st transaction in Michigan.

M&A Deal Summary
Date 2023-10-11
Target Healthmark
Sector Medical Products
Buyer(s) Getinge
Deal Type Add-on Acquisition
Deal Value 320M USD

Target

Healthmark

Fraser, Michigan, United States
Healthmark is a provider of instrument care and infection control consumables. Healthmark was founded in 1969 and is based in Fraser, Michigan.

Search 204,717 Deals Now

SEARCH BY

  • Buyer Type (PE or Strategic)
  • Deal Size ($10M to $10B+)
  • Sector (60 Sectors)
  • Deal Type
  • Geography
  • & More

Try For Free 7-Day Free Trial

Buyer(S) 1

Buyer

Getinge

Gothenburg, Sweden
Category Company
Founded 1904
Sector Medical Products
Employees11,891
Revenue 31.8B SEK (2023)
DESCRIPTION

Getinge is a medical technology company that operates in the areas of surgery, intensive care, infection control, care ergonomics and wound care. Getinge was founded in 1904 and is based in Gothenburg, Sweden.

DEAL STATS #
Overall 10 of 11
Sector (Medical Products) 6 of 7
Type (Add-on Acquisition) 9 of 10
State (Michigan) 1 of 1
Country (United States) 6 of 7
Year (2023) 2 of 2
Size (of disclosed) 2 of 4
PREVIOUS DEAL
DATE TARGET DEAL TYPE VALUE
2023-05-31 HPNE

Smithfield, Rhode Island, United States

HPNE provides a comprehensive range of proprietary and distributed products from drug discovery, upstream and downstream processing, to fill-and-finish. HPNE's products assist leading biopharmaceutical and biotechnology players in the production of monoclonal antibodies, vaccines, cell and gene therapies and other next-generation therapies. HPNE was founded in and is based in Smithfield, Rhode Island.

Buy $290M
FOLLOWING DEAL
DATE TARGET DEAL TYPE VALUE
2024-08-22 Paragonix Technologies

Waltham, Massachusetts, United States

Paragonix Technologies is a developer, manufacturer, and service provider in the organ transplant industry, establishing a novel approach to organ preservation. Paragonix Technologies provides Advanced Organ Preservation (“AOP”) devices that safeguard donor organs during the journey between donor and recipient patients. Paragonix Technologies is based in Waltham, Massachusetts.

Buy -
Mergr

Product

Company

Legal